Stroke Trial, Recruiting NCT07343895 Sponsor: University Hospital of North Norway Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07343895
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 40 years of age or older
  • People whose NT-proBNP level (a blood marker related to heart stress) is above a certain median level (confirm with trial site for the specific value)
  • People who have given their written agreement to take part in the trial

Who may not be able to join:

  • People who have previously been diagnosed with atrial fibrillation (an irregular heart rhythm), based on self-reporting
  • People who are currently taking blood-thinning medication (anticoagulation therapy)
  • People who have a pacemaker or cardiac resynchronisation therapy (CRT) device implanted
  • People who do not have access to a smartphone

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tor Ingenbrigtsen, University Hospital of North Norway

Phone: +4797193417

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital of North Norway
Registry
ClinicalTrials.gov
Start date
24 October 2025
Est. completion
1 March 2032

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Number of participants with the composite outcome of ischemic stroke or cardiovascular death; Number of participants with ischemic stroke; Number of participants with intracerebral hemorrhage; Number of participants with cardiovascular death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov